You are here: Industry Insights > AI

News List

US approval for first AI device to help detect colon cancer pharmatimes
April 13, 2021
The US Food and Drug Administration (FDA) has authorised a new medical device that uses artificial intelligence (AI) based on machine learning to help clinicians detect potentials signs of colon cancer.
EU approval for new AI technology that can predict heart attacks pharmatimes
March 31, 2021
New artificial intelligence (AI) technology that can identify if people are at high risk of having a fatal heart attack before it occurs has been approved in the EU.
University team uses AI to decode asbestos-linked cancer pharmaceutical-technology
March 29, 2021
Researchers at the University of Leicester have used artificial intelligence (AI) to gain new insights into mesothelioma, a cancer caused by breathing asbestos particles that typically occurs in the linings of the lungs or abdomen.
AI and Cloud to Empower the European Telehealth Market Securing Efficient Access to Essential Healthcare Services prnasia
March 18, 2021
Frost & Sullivan's recent analysis, Innovative Business Models Powering the Telehealth Market in Europe, finds that the severe impact of COVID-19 on the healthcare sector across Europe catapulted the use of telehealth.
Antiverse raises £1.4m to bolster AI antibody drug discovery platform pharmatimes
March 17, 2021
Cardiff, Wales-based biotech company Antiverse has raised £1.4m to further advance the development of its AI antibody drug discovery platform.
Aiforia appoints Swedbank as lead advisor to explore financing options prnasia
March 16, 2021
Aiforia Technologies Oy has appointed Swedbank AB (publ) as their lead financial advisor to explore different financing options, including possibilities for an Initial Public Offering (IPO) by listing the Company's shares on Nasdaq Helsinki First North.
Wayra, GE Healthcare launch accelerator programme for digital health start-ups pharmatimes
March 01, 2021
Wayra and GE Healthcare have launched an accelerator programme across the Europe, the Middle East and Africa (EMEA) region to support digital health start-ups to develop AI applications for healthcare.
Regulatory agencies have provided various leverages to adopt digital technologies in business operations expresspharma
February 24, 2021
As a technology partner, tell us how COVID-19 is causing a metamorphosis in the life sciences industry. Which areas of the pharma value chain will see the most far-reaching changes? What will be the drivers?
Windlas Biotech, Mateon Therapeutics partner to launch combined lung therapy and AI telemedicine solution expresspharma
February 23, 2021
The solution consists of three components: the drug PulmoHeal, an AI lung health assessment tool called ArtiHealthand, a post-marketing survey platform.
OSE Immunotherapeutics Expands Collaboration with MAbSilico americanpharmaceuticalreview
February 05, 2021
OSE Immunotherapeutics announced a new collaboration agreement with MAbSilico, a deep technology TechBio located in Tours, France, to use artificial intelligence (AI)-based software for therapeutic monoclonal antibody drug development.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 18 19 Next page